期刊文献+

抗真菌药物敏感性试验 被引量:5

Antifungal susceptibility testing
下载PDF
导出
出处 《中国感染与化疗杂志》 CAS 2009年第2期143-147,共5页 Chinese Journal of Infection and Chemotherapy
基金 上海市卫生局科技发展基金资助项目(054118) 卢湾区卫生系统学科带头人培养计划资助
  • 相关文献

参考文献20

  • 1National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts[S]. Approved standard NCCLS document M27-A2, Villanova, PA, 2002.
  • 2National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi[S]. Approved standard NCCLS document M38-A, Villanova, PA,2002.
  • 3Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeaststhird edition: Approved standard M27-A3[S]. CLSI, Wayne, PA,2008.
  • 4Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi-second edition: Approved standard M38-A2 [S]. CLSI, Wayne, PA, 2008.
  • 5Clinical and Laboratory Standards Institute. Zone diameter interpretive standards and corresponding minimal inhibitory concentration (MIC) interpretive breakpoints[S]. Supplement M44-S1. CLSI,Wayne,PA,2006.
  • 6Clinical and Laboratory Standards Institute. Annual meeting minutes, January 2006[S]. CLSI, Wayne,PA.
  • 7Espinel-Ingroff A, Arthington-Skaggs B, Iqbal N, et al. Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin[J]. J Clin Microbiol,2007,45(6) : 1811-1820.
  • 8Alexander BD,Byrne TC, Smith KL,et al. Comparative evaluation of Etest and sensititre yeastOne panels against the clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal Agents[J]. J Clin Microbiol,2007,45(3) : 698-706.
  • 9Guinea J, Pelaez T, Aleala L, et al. Comparison of Sensititre Yeastone with NCCLS M-38 A microdilution method to determine the activity of amphoteriein B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus[J].Diagn Microbiol and Infect Dis,2006,56(1):53-55.
  • 10Espinel-Ingroff A. Comparison of Three Commercial Assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp. , Candida spp. , and Cryptococcus neoformans with posaconazole and amphotericin B[J]. J Clin Microbiol, 2006, 44(10) : 3616-3622.

二级参考文献13

  • 1刘伟,李若瑜.抗真菌药物敏感性试验在真菌感染防治中的作用[J].中华检验医学杂志,2005,28(4):349-351. 被引量:30
  • 2王澎,陈翠珠,徐英春,谢秀丽,王瑶,王辉,陈民钧.4种抗真菌药对82株丝状真菌体外抗菌活性的临床研究[J].中国实用内科杂志,2006,26(4):547-549. 被引量:5
  • 3M27-A2 Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. 2nd ed. 2002.22(15):1-30.
  • 4M38-A, Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi, Approved Standard. 2002.22(16):1-30.
  • 5Lass-florl C, Kofler G, Kropshofer G, et al. In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis. J Antimicro Chemoth, 1998,42:497-502.
  • 6Pfaller MA, Boyken L, Hollis RJ,et al. In vitro susceptibilities of clinical isolates of Candida species, cryptococcus neoformans, and Aspergillus species to itraconazole:global survey of 9359 isolates tested by Clinical and Laboratory Standards Institute Broth Microdilution Methods. J Clin Microb ,2005,43:3807-3810.
  • 7Willems L, van der C, eest R, de Beule K. Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics. J Clin Phar Ther, 2001,26:159-169.
  • 8Fothergill AW, Rinaldi MG,Sutton DA. Antifungal susceptibility testing. Infect Dis Clin North Am,2006,20:699-700.
  • 9Pfaller MA, Diekema D J, Sheehan DJ. Interpretive breakpoints for fluconazole and Candida revisited: a blueprint of the future for antifungal susceptibility testing. Clin Microbiol Rev,2006,19:435-447.
  • 10Rex JH,Pfaller MA. Has antifungal susceptibility testing come of age? Clin Infect Dis,2002,35:982-989.

共引文献19

同被引文献60

  • 1刘伟,李若瑜.抗真菌药物敏感性试验在真菌感染防治中的作用[J].中华检验医学杂志,2005,28(4):349-351. 被引量:30
  • 2蔡德海,王奕飞,查斯娜.中草药抗真菌研究十年回顾[J].河北医学,2006,12(1):94-96. 被引量:19
  • 3占萍,刘维达.抗真菌药物敏感性试验方法的新进展[J].中国真菌学杂志,2007,2(1):45-48. 被引量:4
  • 4赵景辉,孙秋宁,闫岩,宿斌.申克孢子丝菌双相体外药物敏感试验研究[J].中国麻风皮肤病杂志,2007,23(7):575-578. 被引量:6
  • 5John H R,Barbara D A,David A,et al.Reference method for broth dilution antifungal susceptibility testing of filamentous fungi;approved standard-second edition.Wayne.CLSI document M38-A2[C].Pennsylvania,USA:Clinical and Laboratory Standards Institute,2008:1087-1898.
  • 6Castro C,Serrano M C,Flores B,et al.Comparison of the sensitive yeast colorimetric antifungal panel with a modified NCCLS M38-A method to determine the activity of voriconazole against clinical isolates of Aspergillus spp.[J].Clinic Microbiol,2004,42(9):4358-4360.
  • 7Matar M J,Ostrosky-Zeichner L,Paetznick V L.et al.Correlation between E.test,disk diffusion and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole[J].Antimicrob Agents Chemother,2003,47(5):1647-1651.
  • 8Sabatelli F,Patel R,Mann P A,et al.In vitro activities of posaconazole,fluconazole,itraconazole,voriconazole,and amphotericin B against a large collection of clinical important molds and yeasts[J].Antimicrob Agents Chemother,2006,50(6):2009-2015.
  • 9Ghannoum MA, Kuhn DM. Voriconazole-better chances for patients with invasive mycoses[ J]. Eur J Med Res, 2002,7 ( 5 ) :242-256.
  • 10芦亚君,程宁.3种中药方剂逆转大肠杆菌耐药性的实验观察[J].西北药学杂志,2007,22(6):309-311. 被引量:30

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部